46 results on '"Vescovi, Angelo L."'
Search Results
2. Supplementary Figures from Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
3. Data from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
4. Figure S5 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
5. Figure S3 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
6. Figure S5 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
7. Data from AQP4 Aggregation State Is a Determinant for Glioma Cell Fate
8. Data from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
9. Figure S3 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
10. Figure S4 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
11. Figure S2 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
12. Supplementary Tables from Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
13. Table S1 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
14. Supplementary Data from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
15. Figure S6 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
16. Supplementary Procedures from Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
17. Data from Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
18. Figure S1 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
19. Supplementary Figures from Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
20. Figure S6 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
21. Figure S1 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
22. Data from Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
23. Supplementary Figure s1 from AQP4 Aggregation State Is a Determinant for Glioma Cell Fate
24. Supplementary Tables from Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
25. Figure S4 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
26. Table S1 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
27. Supplementary Procedures from Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
28. Figure S2 from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
29. Supplementary Data from Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
30. Data from AQP4 Aggregation State Is a Determinant for Glioma Cell Fate
31. Supplementary Methods, Figures 1-6 from Endothelial Cells Create a Stem Cell Niche in Glioblastoma by Providing NOTCH Ligands That Nurture Self-Renewal of Cancer Stem-Like Cells
32. Data from Endothelial Cells Create a Stem Cell Niche in Glioblastoma by Providing NOTCH Ligands That Nurture Self-Renewal of Cancer Stem-Like Cells
33. Data from Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
34. Supplementary Figures 1-5, Table 1, Methods and Materials from Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
35. Supplementary Figures 1-5, Table 1, Methods and Materials from Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
36. Data from Endothelial Cells Create a Stem Cell Niche in Glioblastoma by Providing NOTCH Ligands That Nurture Self-Renewal of Cancer Stem-Like Cells
37. Supplementary Methods, Figures 1-6 from Endothelial Cells Create a Stem Cell Niche in Glioblastoma by Providing NOTCH Ligands That Nurture Self-Renewal of Cancer Stem-Like Cells
38. AQP4 Aggregation State Is a Determinant for Glioma Cell Fate
39. Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
40. Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
41. Endothelial Cells Create a Stem Cell Niche in Glioblastoma by Providing NOTCH Ligands That Nurture Self-Renewal of Cancer Stem-Like Cells
42. Abstract 3296: KLF9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells
43. Abstract 3297: Endothelial cells function as a niche to cancer stem-like cells by providing notch ligands in glioblastoma
44. Abstract 4235: Notch ligand-dependent cancer stem cell niche in glioblastoma
45. Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
46. Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.